Ladenburg Thalmann upgraded Edison International (NYSE:EIX) to "neutral" from "sell" given its valuation support following a recent sell-off.

Cellectar Biosciences Inc (CLRB) stock saw a decline, ending the day at $0.25 which represents a decrease of $-0.03 or -10.71% from the prior close of $0.28. The stock opened at $0.26 and touched a ...

Ladenburg Thalmann has recently raised Energous Corp (WATT) stock to Buy rating, as announced on May 16, 2024, according to Finviz. Earlier, on April 5, 2024, Ladenburg Thalmann had reduced the stock ...

Edison stock climbs after steep losses, but wildfire lawsuits and regulatory risks cloud its long-term outlook ...

The catastrophic wildfires in Los Angeles County have rocked the stock of Edison International, the parent company of ...

Artelo Biosciences (NASDAQ:ARTL – Get Free Report)‘s stock had its “buy” rating reissued by D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They currently have a $6.00 price ...

Fintel reports that on January 15, 2025, Ladenburg Thalmann upgraded their outlook for NorthWestern Energy Group ...

Edison International upgraded to Neutral by Ladenburg Thalmann, saying worst-case scenario already factored in.

Ladenburg Thalmann analyst Paul Fremont upgraded Edison to a Neutral rating and set a price target of $56.50 on Wednesday.

Ladenburg analyst Paul Fremont upgraded Edison International (EIX) to Neutral from Sell with a $56.50 price target The firm cites valuation ...

Ladenburg upgraded Edison International (EIX) to Neutral from Sell with a $56.50 price target Stay Ahead of the Market:Discover outperforming ...

Calidi Biotherapeutics, a clinical-stage biotechnology company, disclosed on January 8, 2025, its entry into a Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. The agreement pertains to ...